Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction.
Gabriele MocciaroFrancesco RubinoPublished in: Handbook of experimental pharmacology (2022)
Obesity is a key player in the onset and progression of insulin resistance (IR), a state by which insulin-sensitive cells fail to adequately respond to insulin action. IR is a reversible condition, but if untreated leads to type 2 diabetes alongside increasing cardiovascular risk. The link between obesity and IR has been widely investigated; however, some aspects are still not fully characterized.In this chapter, we introduce key aspects of the pathophysiology of IR and its intimate connection with obesity. Specifically, we focus on the role of adipose tissue dysfunction (quantity, quality, and distribution) as a driver of whole-body IR. Furthermore, we discuss the obesity-related lipidomic remodeling occurring in adipose tissue, liver, and skeletal muscle. Key mechanisms linking lipotoxicity to IR in different tissues and metabolic alterations (i.e., fatty liver and diabetes) and the effect of weight loss on IR are also reported while highlighting knowledge gaps.
Keyphrases
- insulin resistance
- type diabetes
- adipose tissue
- skeletal muscle
- glycemic control
- high fat diet induced
- high fat diet
- weight loss
- metabolic syndrome
- polycystic ovary syndrome
- oxidative stress
- induced apoptosis
- bariatric surgery
- mass spectrometry
- gene expression
- roux en y gastric bypass
- body mass index
- cell proliferation
- quality improvement
- high resolution
- high speed
- endoplasmic reticulum stress
- obese patients